Dr MBA - Telesis Bio Founder Director

TBIODelisted Stock  USD 2.98  0.02  0.67%   

Director

Dr MBA is Founder Director of Telesis Bio
Age 57
Phone858 228 4115
Webhttps://telesisbio.com

Telesis Bio Management Efficiency

The company has return on total asset (ROA) of (0.2652) % which means that it has lost $0.2652 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4784) %, meaning that it created substantial loss on money invested by shareholders. Telesis Bio's management efficiency ratios could be used to measure how well Telesis Bio manages its routine affairs as well as how well it operates its assets and liabilities.
Telesis Bio currently holds 34.38 M in liabilities with Debt to Equity (D/E) ratio of 0.16, which may suggest the company is not taking enough advantage from borrowing. Telesis Bio has a current ratio of 5.81, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Telesis Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Telesis Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Telesis Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Telesis to invest in growth at high rates of return. When we think about Telesis Bio's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Jeremy HobbsAMCON Distributing
57
Susan MurphyAcme United
67
Katherine HarlessToro Co
69
Michael ValeToro Co
54
Richmond HoldenAcme United
65
Janet CooperToro Co
67
Angie SnavelyToro Co
N/A
Alejandro DavilaBBB Foods
46
Luis BermdezBBB Foods
53
Joyce MullenToro Co
58
Stevenson WardAcme United
73
Stanley MayerAMCON Distributing
73
Jeffrey HarmeningToro Co
53
Timothy PestotnikAMCON Distributing
58
Patricia MillerVera Bradley
86
Gary EllisToro Co
64
Pablo GrattarolaBBB Foods
51
Diego ApalateguiBBB Foods
47
Raymond BenteleAMCON Distributing
81
Gregg SteinhafelToro Co
65
Javier SuarezBBB Foods
47
Translate Bio, Inc., a clinical-stage messenger RNA therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company was founded in 2011 and is headquartered in Lexington, Massachusetts. Translate Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people. Telesis Bio [TBIO] is a Pink Sheet which is traded between brokers as part of OTC trading. Telesis Bio is listed under Measuring and Control Equipment category by Fama And French industry classification.

Management Performance

Telesis Bio Leadership Team

Elected by the shareholders, the Telesis Bio's board of directors comprises two types of representatives: Telesis Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Telesis. The board's role is to monitor Telesis Bio's management team and ensure that shareholders' interests are well served. Telesis Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Telesis Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Decky MBA, Senior Development
Laura MBA, Vice Culture
Richard Lepke, Director Relations
Jen Carroll, Vice Relations
Laurence Warden, Senior Instrumentation
William Kullback, Chief Officer
Dr MBA, Founder Director
Daniel Gibson, Chief Officer
Robert Cutler, Chief Officer
Eric Esser, CEO, President

Telesis Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Telesis Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Telesis Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Telesis Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telesis Bio will appreciate offsetting losses from the drop in the long position's value.

Moving against Telesis Pink Sheet

  0.63SYK StrykerPairCorr
  0.62NXL Nexalin TechnologyPairCorr
  0.61PEN PenumbraPairCorr
  0.6VREX Varex Imaging CorpPairCorr
  0.6FNA Paragon 28PairCorr
The ability to find closely correlated positions to Telesis Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telesis Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telesis Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telesis Bio to buy it.
The correlation of Telesis Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Telesis Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Telesis Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Telesis Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Telesis Pink Sheet

If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital